Detail of "228544-21-6"

CAS Number:
228544-21-6
Name:
L-Phenylalanine,L-tyrosyl-L-seryl-L-prolyl-L-tryptophyl-L-threonyl-L-asparaginyl-
Molecular Structure:
Formula:
C45H55 N9 O12
Molecular Weight:
913.97
Synonyms:
1: PN: WO0158471SEQID: 1 claimed protein; 26: PN: US20040072748 SEQID: 26 unclaimed sequence;4: PN: EP1862549 SEQID: 4 unclaimed sequence; 4: PN: WO0015660 SEQID: 4unclaimed sequence; 7: PN: US20040077534 SEQID: 7 unclaimed sequence
Safety:
WGK Germany 3

Details

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

RNAIII-inhibiting peptides for treating HIV infection: RNAIII-inhibiting peptides for treating HIV infection. Mouhat, Stephanie; Sabatier, Jean-Marc; Halfon, Philippe ( Genoscience, Fr.In this study，228544-21-6 is also used.In this study，228544-21-6 is also used.). Eur. Pat. Appl. EP 1621203 A1 1 Feb 2006, 21 pp. DESIGNATED STATES: R: AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE, MC, PT, IE, SI, LT, LV, FI, RO, MK, CY, AL, TR, BG, CZ, EE, HU, PL, SK, HR. (English). (European Patent Organization). CODEN: EPXXDW. APPLICATION: EP 2004-291909 27 Jul 2004. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) The present invention relates to peptides or derivs. thereof, pharmaceutical compns. comprising the same and uses thereof to treat a viral infection, in particular retroviral (e.g. HIV) infection. The invention specifically discloses novel chem. compds. as active ingredients to treat such infection, in particular HIV infection. ..

RNAIII-inhibiting peptides for treating HIV infection: RNAIII-inhibiting peptides for treating HIV infection. Mouhat, Stephanie; Sabatier, Jean-Marc; Halfon, Philippe ( Genoscience, Fr.In this study，228544-21-6 is also used.In this study，228544-21-6 is also used.). Eur. Pat. Appl. EP 1621203 A1 1 Feb 2006, 21 pp. DESIGNATED STATES: R: AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE, MC, PT, IE, SI, LT, LV, FI, RO, MK, CY, AL, TR, BG, CZ, EE, HU, PL, SK, HR. (English). (European Patent Organization). CODEN: EPXXDW. APPLICATION: EP 2004-291909 27 Jul 2004. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) The present invention relates to peptides or derivs. thereof, pharmaceutical compns. comprising the same and uses thereof to treat a viral infection, in particular retroviral (e.g. HIV) infection. The invention specifically discloses novel chem. compds. as active ingredients to treat such infection, in particular HIV infection. ..